Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,301 to 1,320 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Opposing regulation of the Nα-trimethylase METTL11A by its family members METTL11B and METTL13. | J Biol Chem | 2023 | 36889590 | PubTator, text mining | PubMed |
| Severely ill COVID-19 patients have altered circulating levels of proteins controlling the epitranscriptome. | J Infect | 2023 | 36889510 | PubTator, text mining | PubMed |
| The epigenetic regulatory mechanism of PIWI/piRNAs in human cancers. | Mol Cancer | 2023 | 36882835 | PubTator, text mining | PubMed |
| Recent advances in the plant epitranscriptome. | Genome Biol | 2023 | 36882788 | PubTator, text mining | PubMed |
| A novel autophagy-related long non-coding RNAs signature predicting progression-free interval and I-131 therapy benefits in papillary thyroid carcinoma. | Open Med (Wars) | 2023 | 36880066 | PubTator, text mining | PubMed |
| m6A demethylase ALKBH5 attenuates doxorubicin-induced cardiotoxicity via posttranscriptional stabilization of Rasal3. | iScience | 2023 | 36876119 | PubTator, text mining | PubMed |
| Emerging role of interaction between m6A and main ncRNAs in gastrointestinal (GI) cancers. | Front Immunol | 2023 | 36875073 | PubTator, text mining | PubMed |
| Epigenetic reprogramming in pancreatic premalignancy and clinical implications. | Front Oncol | 2023 | 36874143 | PubTator, text mining | PubMed |
| A novel RNA modification prognostic signature for predicting the characteristics of the tumor microenvironment in gastric cancer. | Front Oncol | 2023 | 36874129 | PubTator, text mining | PubMed |
| Targeting fat mass and obesity-associated protein mitigates human colorectal cancer growth in vitro and in a murine model. | Front Oncol | 2023 | 36874096 | PubTator, text mining | PubMed |
| METTL14 Regulates PLAGL2/β-Catenin Signaling Axis to Promote the Development of Nonsmall Cell Lung Cancer. | J Oncol | 2023 | 36873735 | PubTator, text mining | PubMed |
| N6-methyladenosine (m6A) writer METTL3 accelerates the apoptosis of vascular endothelial cells in high glucose. | Heliyon | 2023 | 36873555 | PubTator, text mining | PubMed |
| Identification of m6A/m5C/m1A-associated LncRNAs for prognostic assessment and immunotherapy in pancreatic cancer. | Sci Rep | 2023 | 36871072 | PubTator, text mining | PubMed |
| YTHDF2 exerts tumor-suppressor roles in gastric cancer via up-regulating PPP2CA independently of m6A modification. | Biol Proced Online | 2023 | 36870954 | PubTator, text mining | PubMed |
| Epigenetic reprogramming in cancer: From diagnosis to treatment. | Front Cell Dev Biol | 2023 | 36866275 | PubTator, text mining | PubMed |
| The Comprehensive Analysis of N6-Methyadenosine Writer METTL3 and METTL14 in Gastric Cancer. | J Oncol | 2023 | 36866236 | PubTator, text mining | PubMed |
| LINC00659 cooperated with ALKBH5 to accelerate gastric cancer progression by stabilising JAK1 mRNA in an m6 A-YTHDF2-dependent manner. | Clin Transl Med | 2023 | 36864711 | PubTator, text mining | PubMed |
| Landscape analysis of m6A modification regulators related biological functions and immune characteristics in myasthenia gravis. | J Transl Med | 2023 | 36864526 | PubTator, text mining | PubMed |
| N6-methyladenosine of Spi2a attenuates inflammation and sepsis-associated myocardial dysfunction in mice. | Nat Commun | 2023 | 36864027 | PubTator, text mining | PubMed |
| Identification of m6A regulator-mediated RNA methylation modification patterns and key immune-related genes involved in atrial fibrillation. | Aging (Albany NY) | 2023 | 36863715 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=66